ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2025 Genitourinary Cancers Symposium Merit Awards.

These awards recognize first authors on top-ranking abstracts selected for presentation at the ASCO Genitourinary Cancers Symposium, February 13–15, 2025, in San Francisco, Calif.

These 37 oncology professionals are recognized for their respective field and research advancements within the cancer care community:

Daniela Arduini, MD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS 
William Chen, MD, BS, University of California, San Francisco 
Ruben Del Castillo, MD, Sunnybrook Health Sciences Centre 
Alessandra Dimino, MD, University of Palermo 
Nazli Dizman, MD, The University of Texas MD Anderson Cancer Center 
Anna Dornisch, MD, University of California, San Diego 
Sahil Doshi, MD, Memorial Sloan Kettering Cancer Center 
Hedyeh Ebrahimi, MD, MPH, City of Hope Comprehensive Cancer Center 
Stepan Esagian, MD, NYC Health + Hospitals/Jacobi, Albert Einstein College of Medicine 
Mohammad Arfat Ganiyani, MBBS, Miami Cancer Institute, Baptist Health South Florida 
Diya Garg, BS, Huntsman Cancer Institute at the University of Utah 
Alexander Giesen, MD, UZ Leuven 
Emilio Giunta, MD, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" 
Francesca Jackson-Spence, MBChB (Hons), BMedSc (Hons), PGCAP, Barts Cancer Centre 
Baqir Jafry, MD, MBBS, Charleston Area Medical Center and University of Texas Southwestern 
Jeffrey Johnson, MD, H. Lee Moffitt Cancer Center
Jesus Juarez, MD, University of California, Los Angeles 
Marc Machaalani, MD, Dana-Farber Cancer Institute 
David Maj, MBBS, MSc, Tom Baker Cancer Centre, University of Calgary 
Kendra Marr, MD, PhD, University of Wisconsin Hospitals and Clinics 
Chiara Mercinelli, MD, Medical Oncology Department, IRCCS San Raffaele Hospital 
Masood Moghul, MBBS, BSc (Hons), AKC, PGDip, FRCS (Urol), Royal Marsden Hospital NHS Trust, Institute of Cancer Research  
Mohammad Jad Moussa, MD, MSc, The University of Texas MD Anderson Cancer Center 
Rashad Nawfal, MD, Dana-Farber Cancer Institute 
John Nikitas, MD, University of California, Los Angeles 
Denis Occhipinti, MD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS 
Zeynep Ozay, MD, Huntsman Cancer Insititute at the University of Utah 
Martino Pedrani, MD, Oncology Institute of Southern Switzerland (IOSI) 
Nikhil Pramod, BS, Cleveland Clinic Lerner College of Medicine 
Ryan Rebernick, BS, University of Michigan 
Soumyajit Roy, MD, MBBS, Rush University Medical Center 
Nicolas Sayegh, MD, Huntsman Cancer Institute at the University of Utah 
Alexander Sherry, MD, BS, The University of Texas MD Anderson Cancer Center 
Clara Steiner, MD, Dana-Farber Cancer Institute 
Omid Yazdanpanah, MD, University of California 
Emre Yekeduz, MD, Dana-Farber Cancer Institute 
Ahmet Yildirim, MD, Winship Cancer Institute of Emory University

Conquer Cancer donors help support these awards along with many other resources and programs for oncology professionals, patients, and the cancer community. Learn more.

The 2025 Conquer Cancer® Merit Awards are generously supported by Terri Armstrong, Chris Armstrong, and Mark Gilbert; ASCO Employees; Association of Northern California Oncologists; AstraZeneca; Friends and Family of Dr. and Mrs. Ronald Beller; Dr. and Mrs. Douglas W. Blayney; Bristol Myers Squibb; Jonathan K. and Cora Y. Cho Charitable Fund; Friends, Family, and Colleagues of Dr. Cecil "Pete" Coggins; Michael Craig Cox, PharmD, MHS, BCOP; Trailblazing patient Mark A. Crafts and Generous Supporters of Team Crafty; Bill and Karen Dahut; Allison Dray; Eisai Inc.; Estate of Darla C. Ellis; Epiphany Partners, Inc.; Flatiron Health, Inc.; GlaxoSmithKline Oncology; Harborside; Friends, Colleagues, and Family of Joe Hogan; John Hohneker, MD and Donald Vincent; Melissa M. Hudson, MD, FASCO and Albert E. Weeks, MD; Ipsen Biopharmaceuticals Inc.; Kimberly Irvine; Drs. Kevin Kalinsky and Christopher Keir; Nicole M. Kuderer, MD and Gary H. Lyman, MD, MPH, FASCO; Natasha B. Leighl, MD, FASCO; William T. Leslie, MD; Lilly; Bora Lim, MD and Pavlos Msaouel, MD, PhD; Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company; Maryland/District of Columbia Society of Clinical Oncology; Friends and Colleagues of Theresa Mays; Melanoma Research Foundation; Therese Marie Mulvey, MD, FASCO; Friends and Family of Dr. James B. Nachman; New Rhein Healthcare, LLC; Friends and Colleagues of Dr. Larry Norton; Dr. Kathleen Pritchard Medicine Professional Corporation; The QuadW Foundation; Gabrielle Betty Rocque, MD, MSPH; Sarah Cannon Research Institute; Frances A. Shepherd, MD, FASCO; Stephen A. Sherwin, MD; Drs. Rachna and Puneet Shroff; ASCO’s State Affiliate Council; Stemline, Inc, a Menarini Group Company; Supporters of Innovations and Research in Medical Education; Syndax Pharmaceuticals, Inc.; Nizar M. Tannir, MD; Anthony and Marilyn Tolcher; Dr. Michael and Deborah Troner; and William S. Yaus, Jeffrey W. Yaus, and Kathleen Y. Wolin, ScD.

(This listing is current as of January 27, 2025.)